Profund Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
26,639
-8,842
| -25% | -$82.8K | 0.01% | 789 |
|
|
2025
Q1 | $436K | Buy |
35,481
+933
| +3% | +$11.5K | 0.02% | 519 |
|
|
2024
Q4 | $457K | Buy |
34,548
+387
| +1% | +$5.12K | 0.02% | 565 |
|
|
2024
Q3 | $658K | Buy |
34,161
+930
| +3% | +$17.9K | 0.02% | 427 |
|
|
2024
Q2 | $682K | Sell |
33,231
-25,016
| -43% | -$514K | 0.03% | 402 |
|
|
2024
Q1 | $1.39M | Sell |
58,247
-6,935
| -11% | -$165K | 0.05% | 264 |
|
|
2023
Q4 | $1.41M | Buy |
65,182
+17,140
| +36% | +$370K | 0.06% | 256 |
|
|
2023
Q3 | $698K | Sell |
48,042
-12,799
| -21% | -$186K | 0.04% | 375 |
|
|
2023
Q2 | $1.27M | Buy |
60,841
+8,236
| +16% | +$172K | 0.07% | 260 |
|
|
2023
Q1 | $1.11M | Buy |
+52,605
| New | +$1.11M | 0.07% | 276 |
|